The context-specific association of BRD4 expression with disease-free survival based on the presence of T-bet+ TILs suggests that while the anti-inflammatory treatments against cancer, such as BET inhibitors, may be beneficial in reducing chronic inflammation, they may also reduce the tumor-suppressive, T-bet+ TIL-mediated inflammatory immune response. Here, DNER is linked to cancer.